Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07131683) titled 'hUC-MSC-Exo Therapy for Autoimmune Encephalitis' on Aug. 7.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Xuanwu Hospital, Beijing
Condition:
Autoimmune Encephalitis
Intervention:
Biological: Human umbilical cord mesenchymal stem cell derived exosomes
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: November 1, 2025
Target Sample Size: 38
To know more, visit https://clinicaltrials.gov...